Market Cap ₹111 Cr.
Stock P/E 114.9
P/B 5.1
Current Price ₹3.3
Book Value ₹ 0.6
Face Value 1
52W High ₹4.1
Dividend Yield 0%
52W Low ₹ 0.8
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | 0 |
Profit After Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Adjusted Earnings Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 118 | 10 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Income | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
Total Income | 119 | 10 | 5 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
Total Expenditure | 133 | 9 | 5 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 |
Operating Profit | -14 | 1 | -0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exceptional Income / Expenses | 0 | 7 | -4 | -1 | -4 | -2 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | -19 | 8 | -5 | -1 | -3 | -1 | 1 | 1 | 1 | 1 | 0 | 0 |
Provision for Tax | -6 | 4 | -1 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Tax | -13 | 4 | -3 | -1 | -2 | -1 | 1 | 1 | 1 | 1 | 0 | 0 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2 | 0 | 0 | 0 | 0 |
Profit After Adjustments | -13 | 4 | -3 | -1 | -2 | -1 | 1 | -1 | 1 | 1 | 0 | 0 |
Adjusted Earnings Per Share | -0.4 | 0.1 | -0.1 | -0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 0% | 0% | 0% | -100% |
Operating Profit CAGR | -100% | -100% | -100% | 0% |
PAT CAGR | -100% | -100% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 280% | NA% | NA% | 32% |
ROE Average | 2% | 3% | 3% | -4% |
ROCE Average | 1% | 3% | 3% | -5% |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 27 | 30 | 27 | 25 | 24 | 23 | 23 | 22 | 23 | 24 | 24 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | -3 | 5 | -2 | -2 | -4 | -4 | -4 | -4 | -4 | -4 | -4 |
Total Current Liabilities | 21 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 47 | 37 | 26 | 24 | 21 | 19 | 20 | 19 | 20 | 20 | 21 |
Fixed Assets | 35 | 35 | 23 | 15 | 11 | 8 | 8 | 6 | 6 | 6 | 6 |
Other Non-Current Assets | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Current Assets | 8 | 2 | 3 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 15 |
Total Assets | 47 | 37 | 26 | 24 | 21 | 19 | 20 | 19 | 20 | 20 | 21 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 |
Cash Flow from Operating Activities | 0 | -7 | -5 | -7 | -1 | -2 | -0 | -0 | 1 | -1 | 0 |
Cash Flow from Investing Activities | -0 | 8 | 6 | 7 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Cash Flow from Financing Activities | -0 | -1 | -1 | 0 | 1 | -0 | 0 | 0 | 0 | 0 | 0 |
Net Cash Inflow / Outflow | 0 | -0 | 0 | -0 | 1 | -1 | -0 | -0 | 1 | -1 | 0 |
Closing Cash & Cash Equivalent | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
# | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | -0.39 | 0.11 | -0.1 | -0.04 | -0.05 | -0.03 | 0.02 | 0.02 | 0.03 | 0.03 | 0.01 |
CEPS(Rs) | -0.26 | 0.11 | -0.09 | -0.04 | -0.05 | -0.03 | 0.02 | 0.02 | 0.03 | 0.03 | 0.01 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 0.69 | 0.8 | 0.7 | 0.66 | 0.61 | 0.58 | 0.6 | 0.56 | 0.59 | 0.61 | 0.62 |
Core EBITDA Margin(%) | -11.03 | 6.79 | -3.77 | 0 | 0 | 0 | -844.29 | 0 | 0 | 0 | 0 |
EBIT Margin(%) | -13.99 | 80.52 | -90.47 | 0 | 0 | 0 | 774.14 | 0 | 0 | 0 | 0 |
Pre Tax Margin(%) | -14.12 | 80.5 | -90.52 | 0 | 0 | 0 | 770.78 | 0 | 0 | 0 | 0 |
PAT Margin (%) | -9.76 | 37.3 | -62.14 | 0 | 0 | 0 | 770.78 | 0 | 0 | 0 | 0 |
Cash Profit Margin (%) | -6.38 | 38.05 | -60.26 | 0 | 0 | 0 | 770.78 | 0 | 0 | 0 | 0 |
ROA(%) | -23.59 | 8.51 | -10.14 | -5.81 | -7.2 | -5.14 | 2.86 | 3.29 | 4.57 | 4.29 | 1.65 |
ROE(%) | -44.23 | 14.22 | -12.63 | -6.35 | -7.59 | -5.18 | 2.87 | 3.29 | 4.56 | 4.26 | 1.64 |
ROCE(%) | -54.36 | 25.95 | -16.01 | -5.43 | -11.62 | -4.34 | 2.46 | 2.81 | 3.89 | 3.65 | 1.42 |
Receivable days | 17.02 | 155.91 | 0 | 0 | 0 | 0 | 471.44 | 0 | 0 | 0 | 0 |
Inventory Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Payable days | 67.86 | 496.23 | 68.86 | 0 | 0 | 0 | 335.55 | 0 | 0 | 0 | 0 |
PER(x) | 0 | 1.97 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 84.31 |
Price/Book(x) | 0.39 | 0.26 | 0.38 | 0.27 | 0.29 | 0 | 0 | 0 | 0 | 0 | 1.38 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 0.12 | 1.16 | 2.46 | 0 | 0 | 0 | 500.08 | 0 | 0 | 0 | 0 |
EV/Core EBITDA(x) | -0.97 | 16.25 | -99.69 | 99.78 | 11.25 | 31.5 | 64.6 | 57.41 | 40.97 | 42.86 | 93.57 |
Net Sales Growth(%) | 13.68 | -91.92 | -49.32 | -100 | 0 | 0 | 0 | -100 | 0 | 0 | 0 |
EBIT Growth(%) | -107.32 | 140.59 | -160.31 | 69.28 | -103.07 | 64.66 | 155.69 | 12.7 | 37.28 | -2.5 | -60.12 |
PAT Growth(%) | -119.68 | 126.96 | -189.41 | 54.37 | -11.44 | 36.01 | 154.69 | 13.04 | 37.28 | -2.44 | -60.33 |
EPS Growth(%) | -119.71 | 126.96 | -189.38 | 54.36 | -11.52 | 36.07 | 154.69 | 13.04 | 37.49 | -2.66 | -60.16 |
Debt/Equity(x) | 0.06 | 0.02 | 0 | 0 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 |
Current Ratio(x) | 0.37 | 1.15 | 2.22 | 10.16 | 49.69 | 56.62 | 42.26 | 46.15 | 117.69 | 165.65 | 101.12 |
Quick Ratio(x) | 0.37 | 1.15 | 2.22 | 10.16 | 49.69 | 56.62 | 42.26 | 46.15 | 117.69 | 165.65 | 101.12 |
Interest Cover(x) | -109.7 | 6386.94 | -1625.98 | -642.09 | -170.4 | -72.66 | 230.27 | 722.55 | 722.67 | 1368.81 | 163.21 |
Total Debt/Mcap(x) | 0.18 | 0.1 | 0 | 0 | 0.06 | 0 | 0 | 0 | 0 | 0 | 0 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 39.3 | 39.3 | 39.3 | 39.3 | 39.3 | 39.3 | 39.3 | 40.35 | 40.35 | 40.35 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 60.7 | 60.7 | 60.7 | 60.7 | 60.7 | 60.7 | 60.7 | 59.65 | 59.65 | 59.65 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 13.13 | 13.13 | 13.13 | 13.13 | 13.13 | 13.13 | 13.13 | 13.49 | 13.49 | 13.49 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 20.29 | 20.29 | 20.29 | 20.29 | 20.29 | 20.29 | 20.29 | 19.94 | 19.94 | 19.94 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 33.42 | 33.42 | 33.42 | 33.42 | 33.42 | 33.42 | 33.42 | 33.42 | 33.42 | 33.42 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About